![giovanni cafio brystol myerssquibb email giovanni cafio brystol myerssquibb email](https://www.lamescolanza.com/wp-content/uploads/2015/01/unnamed-2.jpg)
In 2010, he was named senior vice president, Global Commercialization, Oncology and Immunology, before becoming president of the company’s U.S. to assume the role of senior vice president, U.S. In 2004, he was appointed senior vice president, European Marketing and Brand Commercialization. He assumed added responsibility for Greece and Israel in 2001, and for South East Europe in 2003. Giovanni Caforio, our Chairman and CEO joins the STAT Breakthrough Science Summit tomorrow to discuss the future of transformative medicines, taking Liked by Giovanni Caforio Join now to see all. Effective, the date of the company's annual meeting of shareholders, Dr Caforio will succeed the current chairman Lamberto Andreotti, who plans to retire. Giovanni joined Bristol-Myers Squibb in 2000 as vice president and general manager, Italy, in the Worldwide Medicines Group. The board of directors of Bristol-Myers Squibb Company (NYSE:BMY), a biopharmaceutical company, revealed on Wednesday the election of Giovanni Caforio, MD as its chairman. This was preceded by his work as the company’s chief commercial officer. Prior to becoming CEO, Giovanni served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply. As a leader, he is focused on the business value of a company culture that promotes and rewards diversity and inclusion. With a background as a physician, Giovanni has helped strengthen the company’s patient-focused culture - one driven by innovation, speed, accountability and passion. Under his leadership, BMS is evolving its operating model in order to increase speed and competitiveness. In May 2017, he assumed the role of chairman of the board.Īs CEO, Giovanni has led the company’s focus on researching and developing transformational medicines, which includes a leading portfolio of immunotherapies that are fundamentally changing the way cancer is treated. has been chief executive officer of Bristol-Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014. Previously, Dr Caforio was the chief operating officer ofĮnterprise Services and Global Manufacturing & Supply as well as itsĬhief commercial officer at Bristol-Myers.Giovanni Caforio, M.D.
#Giovanni cafio brystol myerssquibb email full#
Other search options: Filter and sort Full text search. Amicus curiae briefs are listed by plaintiff's name. Squibb since May 2015 and has been a member of its board of directors Cases are listed alphabetically by the last name of individual defendants, by company name, or by the entity's first name. Giovanni Nuzzo is an Isf Specialist Hematology at Bristol-Myers Squibb based in New York City, New York.
![giovanni cafio brystol myerssquibb email giovanni cafio brystol myerssquibb email](https://static01.nyt.com/newsgraphics/2017/05/16/exec-comp/assets/ceos/bmy_gc.jpg)
For product side-effect inquiries call (800) 721-5072. Contact us to get the answers to questions related to Bristol Myers Squibb products through our contact form, customer relations line or live chat. Of shareholders, Dr Caforio will succeed the current chairman LambertoĪndreotti was employed as Bristol-Myers Squibb's chiefĮxecutive officer from 2010 to May 2015 and will have served as theĬompany's chairman for two years when Caforio's appointmentĭr Caforio has served as chief executive officer of Bristol-Myers Isf Specialist Hematology at Bristol-Myers Squibb. Contact Bristol Myers Squibb through our contact form, customer relations line or live chat.
![giovanni cafio brystol myerssquibb email giovanni cafio brystol myerssquibb email](https://www.citybiz.co/wp-content/uploads/2021/04/Bristol-Myers-Squibb.png)
The board of directors of Bristol-Myers Squibb Company (NYSE:BMY),Ī biopharmaceutical company, revealed on Wednesday the election ofĮffective, the date of the company's annual meeting M2 EQUITYBITES-December 22, 2016-Bristol-Myers Squibb Company names
#Giovanni cafio brystol myerssquibb email free#
MLA style: "Bristol-Myers Squibb Company names Giovanni Caforio, MD as new chair." The Free Library.